PSYC 210 Lecture Notes - Lecture 18: Striatum, Etiology, Benzodiazepine

34 views7 pages
!"#$%&%'()#*#+,*&-./(
011$23&4#*"+,(56#*(1"$-"%*(27(1"21+"(562(8."(#99&-*&:"(.8;.*#%-".(;"-24"(
#99&-*"9<
=>
0?
9%
B.
@=>
)?
A=>
B?
C6"(-$&*"$&#( 72$(.8;.*#%-"(#;8."(&%-+89"(*6"(72++25&%'(-#*"'2$&"./ D."+"-*(#++(*6#*(
#11+,E
Social+impairment
A.
Physiological+changes
B.
)?
Excessive+risk
D.
G"92%&-("%6#%-"4"%*
H?
I6#*(&.(*6"(42.*(-2442%+,(8."9(.8;.*#%-"(&%(*6"(J%&*"9(K*#*".<
Alcohol
A.
L&-2*&%"
M?
F#$&N8#%#
)?
O1&#*".
B?
P":&"5/
B".-$&1*&2%(#%9(9&#'%2.&.
Q
H*&2+2',
Q
O:"$:&"5/
H*&2+2',/(%"8$2;&2+2',
Q
C$"#*4"%*
Q
Etiology:+Pathophysiology
P"5#$9(#%9(921#4&%"
Addiction+is+a+disease+of+striatal+dopamineQ
0++(9$8'.(27(#;8."(#-*(*2(&%-$"#."(+":"+.(27(921#4&%"(&%(*6"(.*$&#*84
O1&2&9.R(.*&48+#%*.R(;"%S29&#S"1&%".R(#+-262+R(-#%%#;&%2&9.R(9&..2-&#*&:"
Q
H.."%*&#+(72$($"&%72$-&%'(1$21"$*&".(#%9(42*&:#*&2%#+(1$21"$*&".Q
T%-"%*&:"(."%.&*&S#*&2%(*6"2$,
)$#:&%'(DU5#%*&%'UE(:.?(1+"#.8$"(DU+&V&%'UEQ
B0(.,.*"4(;"-24".(.81"$W."%.&*&:"(*2(9&$"-*("77"-*.(27(9$8'.(#%9(#+.2(*2(9$8'W
#..2-&#*"9(-8".
K"%.&*&:&*,(*2(9$8'(#..2-&#*"9(-8".(D5&%"(;2**+".R(%""9+".R("*-?E
B21#4&%"($"+"#."9(*2(42*&:#*"($"5#$9(*2(;"(2;*#&%"9
Q
B21#4&%"(&.(42.*(&412$*#%*(&%(42*&:#*&%'(;"6#:&2$(*2(2;*#&%($"5#$9&%'(.*&48+&Q
K"%.&*&:&*,(WWX(-$#:&%'.
Y2(*2("3*$"4"(+"%'*6.(*2(.""V(28*(#%9(2;*#&%(9$8'.
Q
O:"$(*&4"R(+&V&%'(9"-$"#."R(5#%*&%'($"4#&%.(&%*"%."Q
C$#%.&*&2%(7$24(+&V&%'(WWX(5#%*&%'(4#&%*#&%.(#99&-*&2%R(7#-&+&*#*"9(;,(B0Q
B21#4&%"(6,12*6".&.(27(K)Z
I6"%(.""&%'(1#$*&-8+#$(-8".(&%(42%V",.R(.""(#(+#$'"(.1&V"(&%(921#4&%"(56"%(
.""&%'(N8&-"(2%-"(,28(.""(#(*$&#%'+"
G"#+*6(#%&4#+./(2:"$*&4"(;"'&%(*2(#..2-&#*"(*6"(-8"(5&*6(*6"($"5#$9
[6#.&-(;8$.*(528+9(42:"(*2(#(+&**+"(;"72$"(*6"(N8&-"(2%-"(*6"(
*$&#%'+"(&.(.""%
§
[2.&*&:"(.,41*24./(&%#11$21$&#*"(16#.&-(;8$.*(*2(#(%"8*$#+(2;N"-*
L"'#*&:"(.,41*24./(7#&+"9($".12%."(*2(#-*8#+($"5#$9(-8"
Q
H3*$"4" $".12%."(*2(9$8'.
F8-6(+#$'"$(16#.&-(7&$&%'(-241#$"9(*2(*6"(%2$4
O:"$*&4"(5&*6(-8".R(*6"(.#4"("3*$"4" $".12%."(&.(.""%(*2(*6"(-8"
Q
B&4&%&.6"9($".12%." *2(":"$,*6&%'("+."
Y&:&%'(#(42%V",(-2-#&%"
Y2(;#-V(#%9('&:"(6&4(N8&-"(6"(+2:"9(;"72$"
M"72$"(*6"(-2-#&%"R(*6"$"(528+9(;"(#('&#%*(16#.&-(7&$&%'(*2(N8&-"
L25(*6#*(6"(6#.(*#V"%(-2-#&%"R(6&.(16#.&-(921#4&%"(7&$&%'(5&++(;"(48-6(
7+#**"$
Q
Extreme+response+to+drugs+and+drug+associated+cues+and+a+diminished+
response+to+everything+else
Q
099&-*&2%(&.(#(9&."#."(27($"5#$9(+"#$%&%'(#%9(42*&:#*&2%
)6#%'"(7$24(+&V&%'(*2(5#%*&%'(
Q
Treatment
I6,(92(5"(%""9(6"+1<
I6,(92(5"(%""9(6"+1(*2($"#+&S"( 5"(%""9(#(-6#%'"<Q
L25#9#,.(*6"$"\.(#(68'"(.8$'"(27(5#$%&%'(+#;"+.R(+&V"(2%(-&'#$"**".(#%9(#+-262+R(
#%9(1"21+"(.*&++(8."(*6"4
Q
L2*(#%(&..8"(27(+#-V(27(&%72$4#*&2%(2$("98-#*&2%Q
099&-*&2%(&.(#%(&%*"$*"412$#+(-62&-"(1$2;+"4
M#+#%-&%'(27(&9"#(*2(*#V"(*6"(9$8'(#%9(7""+('229(&%(*6"(424"%*R(;8*(&.(&*(
52$*6(&*(&%(*6"(+2%'(*"$4(#77"-*.(27(+#*"$(6#$4
Q
0++(-6#%-"(;2&+.(925%(*2(-2.*W;"%"7&*
04;&:#+"%-"(&%(.8;.*#%-"(#;8."(9&.2$9"$.(;"-#8."(27(&44"9&#*"(
'$#*&7&-#*&2%(#%9(9"+#,"9(-2%."]8"%-".
Q
K*#'".(27(-6#%'"(429"+(^C$#%.*6"2$"*&-#+(F29"+(27()6#%'"
[$"W-2%*"41+#*&2%^%2(&%*"%*&2%(27(-6#%'&%'(;"6#:&2$Q
)2%*"41+#*&2%^#5#$"(#(1$2;+"4("3&.*._(%2(-244&*4"%*(*2(#-*&2%
P"-2'%&S"(*6"$"(4#,(;"(#(1$2;+"4
I6"$"(42.*(-+&"%*.(.*#$*(56"%(.""V&%'(6"+1
Q
[$"1#$#*&2%^&%*"$".*(812%(*#V&%'(#-*&2%
F2*&:#*"9(*2(;"'&%(#%(#-*&2%
Q
0-*&2%^#-*&:"(429&7&-#*&2%(27(;"6#:&2$Q
F#&%*"%#%-"^.8.*#&%"9(-6#%'"_(%"5(;"6#:&2$($"1+#-".(2+9Q
P"+#1."^7#++(;#-V(&%*2(2+9(1#**"$%.(27(;"6#:&2$Q
F2*&:#*&2%#+(&%*"$:&"5&%'`"%6#%-"4"%*(*$"#*4"%*
F2.*(1"21+"(-24"(&%(#4;&:#+"%*Q
Motivational+interviewing/(#%("77"-*&:"(5#,(27(*#+V&%'(5&*6(1"21+"(#;28*(
-6#%'"
H77"-*&:"(a(":&9"%-"(;#."9
Q
I6,(&.(&*(%"-"..#$,<(I6,(92%\*(1"21+"(%#*8$#++,(-6#%'"(;"6#:&2$(56"%(*6",(
V%25(&*\.(&412$*#%*<
)6#%'"(&.(%2*(]8&-V(#%9("#.,
Q
["21+"(7#-"(4#%,(9"-&.&2%.(*6#*($"]8&$"(.24"(.2$*(27(-6#%'"(#*(":"$,(.*#'"(27(
+&7"
H#$+,(9"-&.&2%./(624"52$VR('2&%'(*2(.-622+
B&77&-8+*(9"-&.&2%.(+#*"$(&%(+&7"/(4"9&-#*&2%(9"-&.&2%.R($"*&$"4"%*R(+&:&%'(
#+2%"
Q
I6"%(-6#%'"(&.(6#$9R(&*(&.(27*"%(%2* ;"-#8."(27(+#-V(27(&%72$4#*&2%R(+#S&%"..R(
2112.&*&2%#+(1"$.2%#+&*,R(2$(9"%&#+
O7*"%(42*&:#*&2%
Q
I6"%(-6#%'"(&.(6#$9R(&*(&.(;"-#8."(27(#4;&:#+"%-"
Ambivalence/(5#%*&%'(#%9(%2*(5#%*&%'(-6#%'"(#*(*6"(.#4"(*&4"
T.(8%-2472$*#;+"(;"-#8."(&*(+"#9.(*2(#%3&"*,(#%9(*68.(1$2-$#.*&%#*&2%R(
56&-6(&.(27*"%(4&.*#V"%(72$($".&.*#%-"
P".&.*#%-"(&.(#(%#*8$#+(#4;&:#+"%-"(27(*6&%V&%'(#;28*(1$2.(#%9(-2%.(
#%9(4#V&%'(#(-6#%'"
§
Q
)#%(6"+1(;,($".2+:&%'(#4;&:#+"%-"(#%9(6"+1("+&-&*(#(1"$.2%\.(25%(42*&:#*&2%(*2(
-6#%'"
Q
K1&$&*(27(FT
Partnership/(&%(FTR(*6"(-28%."+2$(#%9(-+&"%*(#$"(-2++#;2$#*&:"(5&*6("#-6(
2*6"$
Acceptance/(*6"(-28%."+2$($".1"-*.(*6"(-+&"%*\.(#8*2%24,R(.*$"%'*6.R(
12*"%*&#+R(#%9(1"$.1"-*&:"
Compassion/(5"(V""1(*6"(-+&"%*\.(;".*(&%*"$".*(&%(4&%9
Evocation/(*6"(;".*(%2*&2%`&9"#.(#;28*(-6#%'"(-24"(7$24(*6"(-+&"%*
Q
)2$"(.V&++.(DO0PKE
Open+question/(]8".*&2%.(*6#*(-#8."(72$(42$"(*6#%(#(,".(2$(%2(#%.5"$
LO(^.&41+"(,".`%2(#%.5"$.
0$"(,28(&%(1#&%<b
B2(,28(7""+(+&V"(,28\$"(&%(#(.#7"(1+#-"b
§
cHK(^#%.5"$(48.*(;"("31+#&%"9(#%9("31#%9"9(2%
G25(92(,28(7""+<b
I6#*(#$"(*6"(#9:#%*#'".(*2(42:&%'(*2(#(.#7"$(.1#-"<b
§
Affirmations/(.*#*"4"%*.(#;28*(#%,*6&%'(12.&*&:"(*6"(-28%."+2$(%2*&-".(
#;28*(*6"(-+&"%*
UC6&.(&.(6#$9(52$V(,28(#$"(92&%'U
§
UT*(*22V(#(+2*(27(-28$#'"(*2(92(*6#*U
§
Reflections/(8%9"$.*#%9&%'(56#*(*6"(-+&"%*(&.(*6&%V&%'(#%9(7""+&%'(*6"%(
.#,&%'(&*(;#-V(*2(*6"(-+&"%*_(*2(.""(52$+9(*6$28'6(-+&"%*\.(",".(5&*6(
"41#*6,
K*#*"4"%*.R(%2*(]8".*&2%.
§
UT(92%\*(*6&%V(*6#*(T(6#:"([CKBU(^X(Uc28\$"(%2*(.8$"(#;28*(*6"(
9&#'%2.&.(27([CKBU
§
UT\:"(;""%(*6&.(5#,(72$(.2(+2%'R(&*(N8.*(.""4.(+&V"(1#$*(27(4,(
1"$.2%#+&*,U(^X(UK2(#++(27(*6&.(.""4.(%2$4#+(*2(,28U
§
Summaries/(#(+2%'($"7+"-*&2%(27(42$"(*6#%(2%"(-+&"%*(.*#*"4"%*
[$2:&9"(#%(2112$*8%&*,(72$(*6"(-28%."+2$(*2(;"-24"(.*$#*"'&-(#%9(
."+"-*&:"+,(.844#$&S"(-+&"%*\.(25%($"#.2%(72$(-6#%'"
§
Q
[$2-"..".(D."]8"%*&#+E
Engaging/(*6"(1$2-"..(27(".*#;+&.6&%'(#(*$8.*&%'(#%9(48*8#++,($".1"-*78+(
$"+#*&2%.6&1
L""9(#(-2%%"-*&2%(5&*6(-+&"%*(;"72$"(*#+V&%'(#;28*(;"6#:&2$(-6#%'"
§
0%,*6&%'(*6#*(4#V".(-+&"%*(7""+(5"+-24"R(-2472$*#;+"R(8%9"$.*229R(
"*-?
H3-""9&%'("31"-*#*&2%.b
G#:&%'(48*8#+('2#+.b
)+&"%*(+"#:".(7""+&%'(621"78+b
§
0d0(#**8%&%'R(#+&'%&%'R(N2&%&%'(5&*6R(*6"$#1"8*&-($"+#*&2%.6&1
§
B&.W"%'#'&%'
0.."..&%'
0.V&%'(#(;8%-6(27(]8".*&2%.(&44"9&#*"+,
®
b
C"++&%'
C"++&%'(-+&"%*( 625(*2(7&3(1$2;+"4
®
b
[25"$(9&77"$"%*&#+
)24"(#-$2..(#.(#%(#8*62$&*,(7&'8$"
®
b
!#;"+&%'
B"%&#+R(#99&-*R(.*8;;2$%R($".&.*#%*(
®
b
§
Focusing/(#%(2%'2&%'(1$2-"..(27(.""V&%'(#%9(4#&%*#&%&%'(9&$"-*&2%
T%:2+:".(."**&%'`#'$""&%'(2%(#%(#'"%9#
§
I6&+"(-2%.&9"$&%'(*6"(-+&"%*\.('2#+.(#%9(1$&2$&*&".
§
H772$*(*2(-$"#*"(#(-+"#$(9&$"-*&2% 72$(-6#%'"(1+#%
§
Evoking/("+&-&*&%'(#(-+&"%*\.(25%(42*&:#*&2%(72$(-6#%'"
H+&-&*&%'( -6#%'"(*#+V
§
Change+talk/(-+&"%*(.1""-6(*6#*(7#:2$.(42:"4"%*(&%(*6"(9&$"-*&2%(27(
-6#%'"
UT(5#%*RU(UT(5&.6RU(U&*(528+9(.2+:"(1$2;+"4.RU(U*6"($"#.2%.(
#$"U
b
F2$"("%'#'"4"%*(&%(*6&.R(42$"(+&V"+,(*2(-6#%'"(;"6#:&2$b
)#%(#.V(]8".*&2%.(*2('"%"$#*"(-6#%'"(*#+V
I6,(92(,28(5#%*(*2(4#V"(#(-6#%'"<
®
I6#*(#$"(*6"($"#.2%.(*2(-6#%'"<
®
I6#*(528+9(;"(;"%"7&*.(27(-6#%'"<
®
I6#*(528+9(;"(,28$(7&$.*(.*"1<
®
b
§
Planning/(9":"+21&%'(#(.1"-&7&-(-6#%'"(1+#%(*6#*(*6"(-+&"%*(#'$"".(*2(#%9(&.(
5&++&%'(*2(&41+"4"%*
J.&%'(O0PK(.V&++.(*2("%'#'"(-+&"%*R(72-8.(2%(*21&-R("+&-&*(-6#%'"(*#+V
§
Y2&%'(7$24(#('"%"$#+(-2%-"1*(*2(9":"+21&%'(#(KF0PC(1+#%
KF0PC/(.1"-&7&-R(4"#.8$#;+"R(#-6&":#;+"R($"+":#%*R(*&4"9b
§
Q
[.,-62*6"$#1,(*$"#*4"%*.(72$(-6#%'"
I6#*<()2'%&*&2%.(#$28%9(1$2;+"4
)2'%&*&:"(;"6#:&2$#+(*6"$#1,(D)MCE
L2*&-&%'(9&.*2$*&2%(27(-2.*.(#%9(;"%"7&*.(1"$-"1*&2%
§
)2%*&%'"%-,(4#%#'"4"%*/($"+,&%'(2%(12.&*&:"($"&%72$-"4"%*(#%9(
18%&.64"%*(*2(&%-$"#."(#%9(9"-$"#."(;"6#:&2$_($"5#$9.(72$(%2*(
8.&%'(.8;.*#%-"._(18%&.64"%*(72$(8.&%'(.8;.*#%-"
C#V"(0%*#;8."(*2(1$":"%*(#+-262+(&%*#V"(^5&++(4#V"(,28(
:&2+"%*+,(&++
b
§
0--"1*#%-"(#%9(-244&*4"%*(*6"$#1,(D0)CE
e2-8.".(2%(&9"%*&7,&%'(-2$"(:#+8".
§
P"-2'%&S&%'(1$#-*&-".(*6#*(#$"(&%-2%.&.*"%*(5&*6(-2$"(:#+8".
§
Q
G25<(B2(,28(4#V"(#%9(4#&%*#&%(-62&-"
F2*&:#*&2%#+(&%*"$:&"5&%'
e#4&+,(.,.*"4.`&%*"$:"%*&2%
O7*"%*&4".(7#4&+,(2$(-+2."(1"21+"(-#%(;"(#(1#$*(27(*6"(1$2;+"4
H%-28$#'"(8."R(6"+1(*2(2;*#&%(.8;.*#%-"b
§
0;8."$(27*"%(9"%&".(8."R(;8*(*62."(#$28%9(*6"4(-#%('&:"(#(42$"(
#--8$#*"(1&-*8$"
§
[#*&"%*(27*"%*&4".(-#$".(42$"(#;28*(*6"&$(7#4&+,($"+#*&2%.6&1.(*6#%(
*6"&$(*6"$#1&.*($"+#*&2%.6&1
e#4&+,(6"+1.(*2(-2%*&%8"(*2(42*&:#*"(-6#%'"b
§
A@(.*"1
G#:"(4&3"9($".8+*.
§
K""4(*2(52$V(&%(8%-2%*$2++"9(*$&#+.R(;8*(.625(4&%&4#+(9&77"$"%-"(&%(
-2%*$2++"9(*$&#+.(5&*6(A@(.*"1(#%9(1+#-";2
§
0+-262+&-(#%2%,428.(D00E($".12%9.(#$28%9(.1&$&*8#+&*,
)2%-"1*./
[25"$+"..%"..
®
M"+&":&%'(#%9(*8$%&%'(."+7(&%*2(6&'6"$(125"$
®
Y&:&%'(&%(*2(6&'6"$(125"$
®
!22V&%'(5&*6&%(,28$."+7(72$(-6#%'"
®
b
§
Q
[6#$4#-2+2'&-#+(&%*"$:"%*&2%.
0%*#;8."(DHCOGE(72$(#+-262+&.4
F8.*($"4"4;"$(*2(*#V"(&*(#%9(-2%.&.*"%*+,(*#V"(&*
F#V".(,28(:&2+"%*+,(&++(&7(,28(9$&%V(2%(&*
Q
L#+*$"32%"(DHCOG`21&2&9.E
O1&2&9(#%*#'2%&.*(^;&%9.(*2(21&2&9($"-"1*2$.(.2(*6"(9$8'(&.(8%#;+"(*2
0+-262+(^;+2-V.(#-*&:&*,(27("%92$16&%.(*2(;+2-V(*6"(-$#:&%'(#%9(12.&*&:"(
9$&%V&%'("31"$&"%-"
Q
F"*6#92%"(D21&2&9.E
K8;.*&*8*&2%(*6"$#1,(72$(21&2&9.
Q
O1&2&9(#;8."(*$"#*4"%*
K8;.*&*8*&2%(*6"$#1,(DFOP(1#$*&#+(#'2%&.*E
B$8'/(F"*6#92%"(
M&%9.(*2(21&2&9($"-"1*2$
0-*&:#*".($"-"1*2$(#(+&**+"(*2('&:"(.+&'6*(1+"#.8$#;+"("77"-*
P"1+#-&%'(#%(#99&-*&2%(*2(6"$2&%"(*2(#%(#99&-*&2%(27(4"*6#92%"
G#.(+"..(27($".12%."(#.(6"$2&%"
§
I&*69$#5#+(.,41*24.(#$"(+"..(.":"$"
§
Q
0%*#'2%&.*(*6"$#1,(D%2%."+"-*&:"(#%*#'2%&.*E
B$8'/(L#+*$"32%"
M+2-V.($"-"1*2$.(*2(1$":"%*("31"$&"%-"( 27(;"&%'(6&'6
)#%(;"(*#V"%(9#&+,(2$(#(.+25($"+"#."(fg(9#,(9$8'
Q
I&*69$#5#+(4#%#'"4"%*
)+2%&9&%"(D#@(#'2%&.*E
G"+1(5&*6(5&*69$#5#+(.,41*24.
Q
J+*$#W$#1&9(9"*23&7&-#*&2%(DJPBE
L#+*$"32%"(*$"#*4"%*(8%9"$('"%"$#+(#%".*6".&#
K2(,28(92%\*(7""+(5&*69$#5#+
Q
h#--&%#*&2%(D"31"$&4"%*#+E
P"1$298-".(#%*&;29&".(.2(*6"(6"$2&%"(-#%\*(-$2..(*6"(;+229(;$#&%(;#$$&"$
Q
Substance*Abuse*Disorders*II
C68$.9#,R(F#$-6(@@R(@gAi
AA/fg(0F
Unlock document

This preview shows pages 1-2 of the document.
Unlock all 7 pages and 3 million more documents.

Already have an account? Log in
!"#$%&%'()#*#+,*&-./(
011$23&4#*"+,(56#*(1"$-"%*(27(1"21+"(562(8."(#99&-*&:"(.8;.*#%-".(;"-24"(
#99&-*"9<
=>0?
9%B.
@=>)?
A=>B?
C6"(-$&*"$&#( 72$(.8;.*#%-"(#;8."(&%-+89"(*6"(72++25&%'(-#*"'2$&"./ D."+"-*(#++(*6#*(
#11+,E
Social+impairmentA.
Physiological+changesB.
F"42$,(&41#&$4"%*)?
Excessive+riskD.
G"92%&-("%6#%-"4"%*H?
I6#*(&.(*6"(42.*(-2442%+,(8."9(.8;.*#%-"(&%(*6"(J%&*"9(K*#*".<
AlcoholA.
L&-2*&%"M?
F#$&N8#%#)?
O1&#*".B?
P":&"5/
B".-$&1*&2%(#%9(9&#'%2.&.Q
H*&2+2',Q
O:"$:&"5/
H*&2+2',/(%"8$2;&2+2',Q
C$"#*4"%*Q
Etiology:+Pathophysiology
P"5#$9(#%9(921#4&%"
Addiction+is+a+disease+of+striatal+dopamine
Q
0++(9$8'.(27(#;8."(#-*(*2(&%-$"#."(+":"+.(27(921#4&%"(&%(*6"(.*$&#*84
O1&2&9.R(.*&48+#%*.R(;"%S29&#S"1&%".R(#+-262+R(-#%%#;&%2&9.R(9&..2-&#*&:"
Q
H.."%*&#+(72$($"&%72$-&%'(1$21"$*&".(#%9(42*&:#*&2%#+(1$21"$*&".
Q
T%-"%*&:"(."%.&*&S#*&2%(*6"2$,
)$#:&%'(DU5#%*&%'UE(:.?(1+"#.8$"(DU+&V&%'UE
Q
B0(.,.*"4(;"-24".(.81"$W."%.&*&:"(*2(9&$"-*("77"-*.(27(9$8'.(#%9(#+.2(*2(9$8'W
#..2-&#*"9(-8".
K"%.&*&:&*,(*2(9$8'(#..2-&#*"9(-8".(D5&%"(;2**+".R(%""9+".R("*-?E
B21#4&%"($"+"#."9(*2(42*&:#*"($"5#$9(*2(;"(2;*#&%"9
Q
B21#4&%"(&.(42.*(&412$*#%*(&%(42*&:#*&%'(;"6#:&2$(*2(2;*#&%($"5#$9&%'(.*&48+&
Q
K"%.&*&:&*,(WWX(-$#:&%'.
Y2(*2("3*$"4"(+"%'*6.(*2(.""V(28*(#%9(2;*#&%(9$8'.
Q
O:"$(*&4"R(+&V&%'(9"-$"#."R(5#%*&%'($"4#&%.(&%*"%."
Q
C$#%.&*&2%(7$24(+&V&%'(WWX(5#%*&%'(4#&%*#&%.(#99&-*&2%R(7#-&+&*#*"9(;,(B0
Q
B21#4&%"(6,12*6".&.(27(K)Z
I6"%(.""&%'(1#$*&-8+#$(-8".(&%(42%V",.R(.""(#(+#$'"(.1&V"(&%(921#4&%"(56"%(
.""&%'(N8&-"(2%-"(,28(.""(#(*$&#%'+"
G"#+*6(#%&4#+./(2:"$*&4"(;"'&%(*2(#..2-&#*"(*6"(-8"(5&*6(*6"($"5#$9
[6#.&-(;8$.*(528+9(42:"(*2(#(+&**+"(;"72$"(*6"(N8&-"(2%-"(*6"(
*$&#%'+"(&.(.""%
§
[2.&*&:"(.,41*24./(&%#11$21$&#*"(16#.&-(;8$.*(*2(#(%"8*$#+(2;N"-*
L"'#*&:"(.,41*24./(7#&+"9($".12%."(*2(#-*8#+($"5#$9(-8"
Q
H3*$"4" $".12%."(*2(9$8'.
F8-6(+#$'"$(16#.&-(7&$&%'(-241#$"9(*2(*6"(%2$4
O:"$*&4"(5&*6(-8".R(*6"(.#4"("3*$"4" $".12%."(&.(.""%(*2(*6"(-8"
Q
B&4&%&.6"9($".12%." *2(":"$,*6&%'("+."
Y&:&%'(#(42%V",(-2-#&%"
Y2(;#-V(#%9('&:"(6&4(N8&-"(6"(+2:"9(;"72$"
M"72$"(*6"(-2-#&%"R(*6"$"(528+9(;"(#('&#%*(16#.&-(7&$&%'(*2(N8&-"
L25(*6#*(6"(6#.(*#V"%(-2-#&%"R(6&.(16#.&-(921#4&%"(7&$&%'(5&++(;"(48-6(
7+#**"$
Q
Extreme+response+to+drugs+and+drug+associated+cues+and+a+diminished+
response+to+everything+else
Q
099&-*&2%(&.(#(9&."#."(27($"5#$9(+"#$%&%'(#%9(42*&:#*&2%
)6#%'"(7$24(+&V&%'(*2(5#%*&%'(
Q
Treatment
I6,(92(5"(%""9(6"+1<
I6,(92(5"(%""9(6"+1(*2($"#+&S"( 5"(%""9(#(-6#%'"<Q
L25#9#,.(*6"$"\.(#(68'"(.8$'"(27(5#$%&%'(+#;"+.R(+&V"(2%(-&'#$"**".(#%9(#+-262+R(
#%9(1"21+"(.*&++(8."(*6"4
Q
L2*(#%(&..8"(27(+#-V(27(&%72$4#*&2%(2$("98-#*&2%Q
099&-*&2%(&.(#%(&%*"$*"412$#+(-62&-"(1$2;+"4
M#+#%-&%'(27(&9"#(*2(*#V"(*6"(9$8'(#%9(7""+('229(&%(*6"(424"%*R(;8*(&.(&*(
52$*6(&*(&%(*6"(+2%'(*"$4(#77"-*.(27(+#*"$(6#$4
Q
0++(-6#%-"(;2&+.(925%(*2(-2.*W;"%"7&*
04;&:#+"%-"(&%(.8;.*#%-"(#;8."(9&.2$9"$.(;"-#8."(27(&44"9&#*"(
'$#*&7&-#*&2%(#%9(9"+#,"9(-2%."]8"%-".
Q
K*#'".(27(-6#%'"(429"+(^C$#%.*6"2$"*&-#+(F29"+(27()6#%'"
[$"W-2%*"41+#*&2%^%2(&%*"%*&2%(27(-6#%'&%'(;"6#:&2$Q
)2%*"41+#*&2%^#5#$"(#(1$2;+"4("3&.*._(%2(-244&*4"%*(*2(#-*&2%
P"-2'%&S"(*6"$"(4#,(;"(#(1$2;+"4
I6"$"(42.*(-+&"%*.(.*#$*(56"%(.""V&%'(6"+1
Q
[$"1#$#*&2%^&%*"$".*(812%(*#V&%'(#-*&2%
F2*&:#*"9(*2(;"'&%(#%(#-*&2%
Q
0-*&2%^#-*&:"(429&7&-#*&2%(27(;"6#:&2$Q
F#&%*"%#%-"^.8.*#&%"9(-6#%'"_(%"5(;"6#:&2$($"1+#-".(2+9Q
P"+#1."^7#++(;#-V(&%*2(2+9(1#**"$%.(27(;"6#:&2$Q
F2*&:#*&2%#+(&%*"$:&"5&%'`"%6#%-"4"%*(*$"#*4"%*
F2.*(1"21+"(-24"(&%(#4;&:#+"%*Q
Motivational+interviewing/(#%("77"-*&:"(5#,(27(*#+V&%'(5&*6(1"21+"(#;28*(
-6#%'"
H77"-*&:"(a(":&9"%-"(;#."9
Q
I6,(&.(&*(%"-"..#$,<(I6,(92%\*(1"21+"(%#*8$#++,(-6#%'"(;"6#:&2$(56"%(*6",(
V%25(&*\.(&412$*#%*<
)6#%'"(&.(%2*(]8&-V(#%9("#.,
Q
["21+"(7#-"(4#%,(9"-&.&2%.(*6#*($"]8&$"(.24"(.2$*(27(-6#%'"(#*(":"$,(.*#'"(27(
+&7"
H#$+,(9"-&.&2%./(624"52$VR('2&%'(*2(.-622+
B&77&-8+*(9"-&.&2%.(+#*"$(&%(+&7"/(4"9&-#*&2%(9"-&.&2%.R($"*&$"4"%*R(+&:&%'(
#+2%"
Q
I6"%(-6#%'"(&.(6#$9R(&*(&.(27*"%(%2* ;"-#8."(27(+#-V(27(&%72$4#*&2%R(+#S&%"..R(
2112.&*&2%#+(1"$.2%#+&*,R(2$(9"%&#+
O7*"%(42*&:#*&2%
Q
I6"%(-6#%'"(&.(6#$9R(&*(&.(;"-#8."(27(#4;&:#+"%-"
Ambivalence/(5#%*&%'(#%9(%2*(5#%*&%'(-6#%'"(#*(*6"(.#4"(*&4"
T.(8%-2472$*#;+"(;"-#8."(&*(+"#9.(*2(#%3&"*,(#%9(*68.(1$2-$#.*&%#*&2%R(
56&-6(&.(27*"%(4&.*#V"%(72$($".&.*#%-"
P".&.*#%-"(&.(#(%#*8$#+(#4;&:#+"%-"(27(*6&%V&%'(#;28*(1$2.(#%9(-2%.(
#%9(4#V&%'(#(-6#%'"
§
Q
)#%(6"+1(;,($".2+:&%'(#4;&:#+"%-"(#%9(6"+1("+&-&*(#(1"$.2%\.(25%(42*&:#*&2%(*2(
-6#%'"
Q
K1&$&*(27(FT
Partnership/(&%(FTR(*6"(-28%."+2$(#%9(-+&"%*(#$"(-2++#;2$#*&:"(5&*6("#-6(
2*6"$
Acceptance/(*6"(-28%."+2$($".1"-*.(*6"(-+&"%*\.(#8*2%24,R(.*$"%'*6.R(
12*"%*&#+R(#%9(1"$.1"-*&:"
Compassion/(5"(V""1(*6"(-+&"%*\.(;".*(&%*"$".*(&%(4&%9
Evocation/(*6"(;".*(%2*&2%`&9"#.(#;28*(-6#%'"(-24"(7$24(*6"(-+&"%*
Q
)2$"(.V&++.(DO0PKE
Open+question/(]8".*&2%.(*6#*(-#8."(72$(42$"(*6#%(#(,".(2$(%2(#%.5"$
LO(^.&41+"(,".`%2(#%.5"$.
0$"(,28(&%(1#&%<b
B2(,28(7""+(+&V"(,28\$"(&%(#(.#7"(1+#-"b
§
cHK(^#%.5"$(48.*(;"("31+#&%"9(#%9("31#%9"9(2%
G25(92(,28(7""+<b
I6#*(#$"(*6"(#9:#%*#'".(*2(42:&%'(*2(#(.#7"$(.1#-"<b
§
Affirmations/(.*#*"4"%*.(#;28*(#%,*6&%'(12.&*&:"(*6"(-28%."+2$(%2*&-".(
#;28*(*6"(-+&"%*
UC6&.(&.(6#$9(52$V(,28(#$"(92&%'U
§
UT*(*22V(#(+2*(27(-28$#'"(*2(92(*6#*U
§
Reflections/(8%9"$.*#%9&%'(56#*(*6"(-+&"%*(&.(*6&%V&%'(#%9(7""+&%'(*6"%(
.#,&%'(&*(;#-V(*2(*6"(-+&"%*_(*2(.""(52$+9(*6$28'6(-+&"%*\.(",".(5&*6(
"41#*6,
K*#*"4"%*.R(%2*(]8".*&2%.
§
UT(92%\*(*6&%V(*6#*(T(6#:"([CKBU(^X(Uc28\$"(%2*(.8$"(#;28*(*6"(
9&#'%2.&.(27([CKBU
§
UT\:"(;""%(*6&.(5#,(72$(.2(+2%'R(&*(N8.*(.""4.(+&V"(1#$*(27(4,(
1"$.2%#+&*,U(^X(UK2(#++(27(*6&.(.""4.(%2$4#+(*2(,28U
§
Summaries/(#(+2%'($"7+"-*&2%(27(42$"(*6#%(2%"(-+&"%*(.*#*"4"%*
[$2:&9"(#%(2112$*8%&*,(72$(*6"(-28%."+2$(*2(;"-24"(.*$#*"'&-(#%9(
."+"-*&:"+,(.844#$&S"(-+&"%*\.(25%($"#.2%(72$(-6#%'"
§
Q
[$2-"..".(D."]8"%*&#+E
Engaging/(*6"(1$2-"..(27(".*#;+&.6&%'(#(*$8.*&%'(#%9(48*8#++,($".1"-*78+(
$"+#*&2%.6&1
L""9(#(-2%%"-*&2%(5&*6(-+&"%*(;"72$"(*#+V&%'(#;28*(;"6#:&2$(-6#%'"
§
0%,*6&%'(*6#*(4#V".(-+&"%*(7""+(5"+-24"R(-2472$*#;+"R(8%9"$.*229R(
"*-?
H3-""9&%'("31"-*#*&2%.b
G#:&%'(48*8#+('2#+.b
)+&"%*(+"#:".(7""+&%'(621"78+b
§
0d0(#**8%&%'R(#+&'%&%'R(N2&%&%'(5&*6R(*6"$#1"8*&-($"+#*&2%.6&1
§
B&.W"%'#'&%'
0.."..&%'
0.V&%'(#(;8%-6(27(]8".*&2%.(&44"9&#*"+,
®
b
C"++&%'
C"++&%'(-+&"%*( 625(*2(7&3(1$2;+"4
®
b
[25"$(9&77"$"%*&#+
)24"(#-$2..(#.(#%(#8*62$&*,(7&'8$"
®
b
!#;"+&%'
B"%&#+R(#99&-*R(.*8;;2$%R($".&.*#%*(
®
b
§
Focusing/(#%(2%'2&%'(1$2-"..(27(.""V&%'(#%9(4#&%*#&%&%'(9&$"-*&2%
T%:2+:".(."**&%'`#'$""&%'(2%(#%(#'"%9#
§
I6&+"(-2%.&9"$&%'(*6"(-+&"%*\.('2#+.(#%9(1$&2$&*&".
§
H772$*(*2(-$"#*"(#(-+"#$(9&$"-*&2% 72$(-6#%'"(1+#%
§
Evoking/("+&-&*&%'(#(-+&"%*\.(25%(42*&:#*&2%(72$(-6#%'"
H+&-&*&%'( -6#%'"(*#+V
§
Change+talk/(-+&"%*(.1""-6(*6#*(7#:2$.(42:"4"%*(&%(*6"(9&$"-*&2%(27(
-6#%'"
UT(5#%*RU(UT(5&.6RU(U&*(528+9(.2+:"(1$2;+"4.RU(U*6"($"#.2%.(
#$"U
b
F2$"("%'#'"4"%*(&%(*6&.R(42$"(+&V"+,(*2(-6#%'"(;"6#:&2$b
)#%(#.V(]8".*&2%.(*2('"%"$#*"(-6#%'"(*#+V
I6,(92(,28(5#%*(*2(4#V"(#(-6#%'"<
®
I6#*(#$"(*6"($"#.2%.(*2(-6#%'"<
®
I6#*(528+9(;"(;"%"7&*.(27(-6#%'"<
®
I6#*(528+9(;"(,28$(7&$.*(.*"1<
®
b
§
Planning/(9":"+21&%'(#(.1"-&7&-(-6#%'"(1+#%(*6#*(*6"(-+&"%*(#'$"".(*2(#%9(&.(
5&++&%'(*2(&41+"4"%*
J.&%'(O0PK(.V&++.(*2("%'#'"(-+&"%*R(72-8.(2%(*21&-R("+&-&*(-6#%'"(*#+V
§
Y2&%'(7$24(#('"%"$#+(-2%-"1*(*2(9":"+21&%'(#(KF0PC(1+#%
KF0PC/(.1"-&7&-R(4"#.8$#;+"R(#-6&":#;+"R($"+":#%*R(*&4"9b
§
Q
[.,-62*6"$#1,(*$"#*4"%*.(72$(-6#%'"
I6#*<()2'%&*&2%.(#$28%9(1$2;+"4
)2'%&*&:"(;"6#:&2$#+(*6"$#1,(D)MCE
L2*&-&%'(9&.*2$*&2%(27(-2.*.(#%9(;"%"7&*.(1"$-"1*&2%
§
)2%*&%'"%-,(4#%#'"4"%*/($"+,&%'(2%(12.&*&:"($"&%72$-"4"%*(#%9(
18%&.64"%*(*2(&%-$"#."(#%9(9"-$"#."(;"6#:&2$_($"5#$9.(72$(%2*(
8.&%'(.8;.*#%-"._(18%&.64"%*(72$(8.&%'(.8;.*#%-"
C#V"(0%*#;8."(*2(1$":"%*(#+-262+(&%*#V"(^5&++(4#V"(,28(
:&2+"%*+,(&++
b
§
0--"1*#%-"(#%9(-244&*4"%*(*6"$#1,(D0)CE
e2-8.".(2%(&9"%*&7,&%'(-2$"(:#+8".
§
P"-2'%&S&%'(1$#-*&-".(*6#*(#$"(&%-2%.&.*"%*(5&*6(-2$"(:#+8".
§
Q
G25<(B2(,28(4#V"(#%9(4#&%*#&%(-62&-"
F2*&:#*&2%#+(&%*"$:&"5&%'
e#4&+,(.,.*"4.`&%*"$:"%*&2%
O7*"%*&4".(7#4&+,(2$(-+2."(1"21+"(-#%(;"(#(1#$*(27(*6"(1$2;+"4
H%-28$#'"(8."R(6"+1(*2(2;*#&%(.8;.*#%-"b
§
0;8."$(27*"%(9"%&".(8."R(;8*(*62."(#$28%9(*6"4(-#%('&:"(#(42$"(
#--8$#*"(1&-*8$"
§
[#*&"%*(27*"%*&4".(-#$".(42$"(#;28*(*6"&$(7#4&+,($"+#*&2%.6&1.(*6#%(
*6"&$(*6"$#1&.*($"+#*&2%.6&1
e#4&+,(6"+1.(*2(-2%*&%8"(*2(42*&:#*"(-6#%'"b
§
A@(.*"1
G#:"(4&3"9($".8+*.
§
K""4(*2(52$V(&%(8%-2%*$2++"9(*$&#+.R(;8*(.625(4&%&4#+(9&77"$"%-"(&%(
-2%*$2++"9(*$&#+.(5&*6(A@(.*"1(#%9(1+#-";2
§
0+-262+&-(#%2%,428.(D00E($".12%9.(#$28%9(.1&$&*8#+&*,
)2%-"1*./
[25"$+"..%"..
®
M"+&":&%'(#%9(*8$%&%'(."+7(&%*2(6&'6"$(125"$
®
Y&:&%'(&%(*2(6&'6"$(125"$
®
!22V&%'(5&*6&%(,28$."+7(72$(-6#%'"
®
b
§
Q
[6#$4#-2+2'&-#+(&%*"$:"%*&2%.
0%*#;8."(DHCOGE(72$(#+-262+&.4
F8.*($"4"4;"$(*2(*#V"(&*(#%9(-2%.&.*"%*+,(*#V"(&*
F#V".(,28(:&2+"%*+,(&++(&7(,28(9$&%V(2%(&*
Q
L#+*$"32%"(DHCOG`21&2&9.E
O1&2&9(#%*#'2%&.*(^;&%9.(*2(21&2&9($"-"1*2$.(.2(*6"(9$8'(&.(8%#;+"(*2
0+-262+(^;+2-V.(#-*&:&*,(27("%92$16&%.(*2(;+2-V(*6"(-$#:&%'(#%9(12.&*&:"(
9$&%V&%'("31"$&"%-"
Q
F"*6#92%"(D21&2&9.E
K8;.*&*8*&2%(*6"$#1,(72$(21&2&9.
Q
O1&2&9(#;8."(*$"#*4"%*
K8;.*&*8*&2%(*6"$#1,(DFOP(1#$*&#+(#'2%&.*E
B$8'/(F"*6#92%"(
M&%9.(*2(21&2&9($"-"1*2$
0-*&:#*".($"-"1*2$(#(+&**+"(*2('&:"(.+&'6*(1+"#.8$#;+"("77"-*
P"1+#-&%'(#%(#99&-*&2%(*2(6"$2&%"(*2(#%(#99&-*&2%(27(4"*6#92%"
G#.(+"..(27($".12%."(#.(6"$2&%"
§
I&*69$#5#+(.,41*24.(#$"(+"..(.":"$"
§
Q
0%*#'2%&.*(*6"$#1,(D%2%."+"-*&:"(#%*#'2%&.*E
B$8'/(L#+*$"32%"
M+2-V.($"-"1*2$.(*2(1$":"%*("31"$&"%-"( 27(;"&%'(6&'6
)#%(;"(*#V"%(9#&+,(2$(#(.+25($"+"#."(fg(9#,(9$8'
Q
I&*69$#5#+(4#%#'"4"%*
)+2%&9&%"(D#@(#'2%&.*E
G"+1(5&*6(5&*69$#5#+(.,41*24.
Q
J+*$#W$#1&9(9"*23&7&-#*&2%(DJPBE
L#+*$"32%"(*$"#*4"%*(8%9"$('"%"$#+(#%".*6".&#
K2(,28(92%\*(7""+(5&*69$#5#+
Q
h#--&%#*&2%(D"31"$&4"%*#+E
P"1$298-".(#%*&;29&".(.2(*6"(6"$2&%"(-#%\*(-$2..(*6"(;+229(;$#&%(;#$$&"$
Q
Substance*Abuse*Disorders*II
C68$.9#,R(F#$-6(@@R(@gAi AA/fg(0F
Unlock document

This preview shows pages 1-2 of the document.
Unlock all 7 pages and 3 million more documents.

Already have an account? Log in

Document Summary

The criteria for substance abuse include the following categories: (select all that apply) All drugs of abuse act to increase levels of dopamine in the striatum. Da system becomes super-sensitive to direct effects of drugs and also to drug- associated cues. Sensitivity to drug associated cues (wine bottles, needles, etc. ) Dopamine released to motivate reward to be obtained. Dopamine is most important in motivating behavior to obtain rewarding stimuli. Go to extreme lengths to seek out and obtain drugs. Transition from liking --> wanting maintains addiction, facilitated by da. When seeing particular cues in monkeys, see a large spike in dopamine when seeing juice once you see a triangle. Health animals: overtime begin to associate the cue with the reward. Phasic burst would move to a little before the juice once the triangle is seen. Positive symptoms: inappropriate phasic burst to a neutral object. Negative symptoms: failed response to actual reward cue. Much larger phasic firing compared to the norm.

Get access

Grade+20% off
$8 USD/m$10 USD/m
Billed $96 USD annually
Grade+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
40 Verified Answers
Class+
$8 USD/m
Billed $96 USD annually
Class+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
30 Verified Answers

Related Documents